Nisa Investment Advisors’s HilleVax HLVX Stock Holding History

Nisa Investment Advisors’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-353	Closed	-$702	–	3029
2025 Q2	$702	Buy	353 +234	+197%	+$428	﹤0.01%	2810
2025 Q1	$173	Sell	119 -1,402	-92%	-$2.59K	﹤0.01%	2937
2024 Q4	$3.15K	Buy	1,521 +1,399	+1,147%	+$2.63K	﹤0.01%	2381
2024 Q3	$215	Buy	122 +109	+838%	+$280	﹤0.01%	2842
2024 Q2	$188	Buy	13 +9	+225%	+$124	﹤0.01%	2824
2024 Q1	$67	Buy	+4	New	+$64	﹤0.01%	2734
2023 Q4	–	Sell	-13	Closed	-$175	–	2682
2023 Q3	$175	Buy	+13	New	+$183	﹤0.01%	2683

Nisa Investment Advisors's HLVX Position: Q3 2025 in Review

Nisa Investment Advisors sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 353 shares — an estimated $702 sold.

Nisa Investment Advisors first reported a position in HLVX in Q3 2023 and held it in 7 quarters. The position peaked at $3.15K in Q4 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

Nisa Investment Advisors reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
Nisa Investment Advisors sold 353 HilleVax shares in Q3 2025, an estimated $702.
Nisa Investment Advisors first reported a position in HilleVax in Q3 2023 and held it in 7 quarters.
Nisa Investment Advisors's HilleVax position peaked at $3.15K in Q4 2024.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Nisa Investment Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.